Neonatal Spinal Muscular Atrophy (SMA) Screening
Recruiting
Observational Study
Spinal Muscular Atrophy
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 0 Weeks – 2 Weeks
- Sex
- Any
- Study type
- Observational
- Participants needed
- 250,000 (estimated)
- Sponsor
- Kaohsiung Medical University Chung-Ho Memorial Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Parents or legal guardian of neonates who signed agreement will receive SMA screening test if their neonates are affected with SMA. The dried blood spots of routine newborn screening samples will be used to test if neonates have lost 2 copies of SMN1 gene. If neonates have positive SMA screening test, further confirmation with multiplex ligation-dependent probe amplification (MLPA) test and prospe…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
1. Neonates born in Taiwan who receive regular newborn screening suggested by Ministry of Heath and Welfare.
2. Parents or legal guardian agree to perform SMA newborn screening.
Exclusion Criteria:
Parents or legal guardian do not agree to perform SMA newborn screening.
Contacts